Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 6.9 |
| Revenue growth | | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 7.7 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | -0.9 |
| Gross margin | | | | | -12.6% |
| Research and development | 23.3 | 14.1 | 7.5 | 8.8 | |
| General and administrative | 13.6 | 11.1 | 4.8 | 1.5 | 0.9 |
| EBIT | -36.9 | -25.2 | -12.3 | -10.3 | -7.7 |
| EBIT margin | | | | | -112.6% |
| Pre-tax income | -36.9 | -24.7 | -17.8 | -10.4 | -7.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -37.5 | -24.7 | -17.8 | -10.4 | -7.8 |
| Net margin | | | | | -114.1% |
| |
| Diluted EPS | ($3.09) | ($2.14) | ($5.25) | ($9.51) | ($7.22) |
| Shares outstanding (diluted) | 12.1 | 11.5 | 3.4 | 1.1 | 1.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|